Adam C. Lenain

Recent Representative Transactions

• Represented public life sciences company in a $50,000,000 follow on public offering.
• Represent public life sciences companies in connection with ’34 Act reporting and proxy matters
• Represented private life sciences company in a reverse merger into a Nasdaq listed public company.
• Represented public life sciences company in a $25,000,000 PIPE transaction.
• Represented private life sciences company in a $40,000,000 private equity financing.
• Represented private life sciences company in a $20,000,000 private equity financing.
• Represented private information technology company in a $8,830,000 preferred stock financing.
• Represented private information technology company in a $4,500,000 preferred stock financing.
• Represented private information technology company in a $28,000,000 preferred stock financing.
• Represented private information technology company in a $4,000,000 preferred stock financing.
• Represented private information technology company in a $5,000,000 venture debt transaction.
• Represented private information technology company in a stock-for-stock acquisition
• Represented private information technology company in a $1,250,000 convertible note financing.
• Represented private information technology company in a $900,000 convertible note financing.
• Represented private information technology company in a complex acquisition with earnout.
• Represented private green chemistry company in a $1,000,000 line of credit transaction.
• Represented private life sciences company in a $20,500,000 equity financing.
• Represented private information technology company in a $1,000,000 convertible note financing.